IBB (Nasdaq Biotechnology) Stock Analysis - Politician Trades

Nasdaq Biotechnology (IBB) is a publicly traded the market company. As of May 20, 2026, IBB trades at $167.69 with a market cap of $0 and a P/E ratio of 0.00. IBB moved +2.20% today. Year to date, IBB is +0.00%; over the trailing twelve months it is flat. Its 52-week range spans $0.00 to $0.00. Rallies surfaces IBB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded IBB stock?

Rallies tracks politician and congressional stock disclosures for IBB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.

IBB Key Metrics

Key financial metrics for IBB
MetricValue
Price$167.69
Market Cap$0
P/E Ratio0.00
EPS$0.00
Dividend Yield0.00%
52-Week High$0.00
52-Week Low$0.00
Volume1.77M
Avg Volume0
Revenue (TTM)$0
Net Income$0
Gross Margin0.00%

Latest IBB News

IBB Analyst Consensus

IBB analyst coverage data. Average price target: $0.00.

Common questions about IBB

Which politicians traded IBB stock?
Rallies tracks politician and congressional stock disclosures for IBB, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
Does Rallies track congressional trades in IBB?
Yes. Rallies tracks politician and congressional stock disclosures for IBB, including reported purchases, sales, dates, owners, and trade amounts when available.
Is IBB research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IBB. It does not provide personalized investment advice.
IBB

Nasdaq Biotechnology